Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer.
Saved in:
| Title: | Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer. |
|---|---|
| Authors: | Kian W; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Christopoulos P; Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital, Member of the German Center for Lung Research (DZL), and Translational Lung Research Heidelberg, Heidelberg, Germany., Remilah AA; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Levison E; Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Dudnik E; Thoracic Cancer Service, Assuta Medical Centers, Ben-Gurion University, Tel-Aviv, Israel., Shalata W; The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel., Krayim B; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Marei R; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Yakobson A; The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel., Faehling M; Department of Pneumology, Esslingen Hospital, Esslingen, Germany., Kahala D; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Sara Granot I; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Levitas D; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Peled N; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Roisman LC; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. |
| Source: | Frontiers in oncology [Front Oncol] 2022 Sep 20; Vol. 12, pp. 1010311. Date of Electronic Publication: 2022 Sep 20 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
